chr17-7559230-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000338784.9(TNFSF13):c.191G>A(p.Arg64Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,610,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R64W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000338784.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFSF13 | NM_003808.4 | c.191G>A | p.Arg64Gln | missense_variant | 1/6 | ENST00000338784.9 | NP_003799.1 | |
TNFSF12-TNFSF13 | NM_172089.4 | c.499-394G>A | intron_variant | NP_742086.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFSF13 | ENST00000338784.9 | c.191G>A | p.Arg64Gln | missense_variant | 1/6 | 1 | NM_003808.4 | ENSP00000343505 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000413 AC: 1AN: 241936Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 132192
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1458354Hom.: 0 Cov.: 30 AF XY: 0.00000965 AC XY: 7AN XY: 725394
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.191G>A (p.R64Q) alteration is located in exon 1 (coding exon 1) of the TNFSF13 gene. This alteration results from a G to A substitution at nucleotide position 191, causing the arginine (R) at amino acid position 64 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at